Data & Analysis
Data & Analysis · page 2
- Data & Analysis
Is Cannabis Legal in Germany in 2026? The Law, the Market and What It Means for Operators
Is cannabis legal in Germany? No, not in the way it is in the majority of US states or Canada.
- Industry Trends
What’s in Store for the Global Cannabis Industry in 2026? Mid-Year Update
This article was updated on September 02, 2026 In December 2025, we asked our in-house team of experts how they expected to see the industry evolve over the coming year.
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
- Medical Cannabis
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct a formal review of the UK’s medical cannabis industry.
- Industry Trends
Global Cannabis Use Up 40% Over Last Decade as Reform Spreads, but Overlap With Illicit Market Growing
Use of cannabis across the globe has grown by 40% over the last decade, with 256m people now reported to have used cannabis over the past year in 2024.
- UK & Europe
New Report: Germany’s Cannabis Market Crosses €1.15bn as Reimbursement Era Ends
Germany’s medical cannabis market reached approximately €1.15bn in 2026, with private self-pay prescriptions now generating around 75% of total market value, according to a new whitepaper published today by Business of Cannabis and Prohibition Partners.
- Medical Cannabis
Cannabis Use Among Teens Flat After German Partial Legalisation, But Medical Market Continues Rapid Expansion
Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research adding to the growing body of evidence contradicting the harms predicted by the reform’s critics.
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- Cultivation
Cannabis Inherits Its Future: What the Eye Can’t See
‘Cannabis Inherits Its Future’ is a three-part feature covering the science, the bottlenecks and the path forward for cannabis breeding, written by Agential Cannabis.
- Industry Trends
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.
- International Regulation
How Countries Legalise Cannabis Matters More Than Whether They Do, Lancet Review Finds
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
- Data & Analysis
European Cannabis Insights Summit 2026: Patients & Politics Post-Reclassification
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry.
